...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Level 2 for ZHCLF?

Does anyone have Level 2 access for OTC? We can probably get a snapshot of how many shares available at a moment in time.

Share
New Message
Please login to post a reply